The preclinical-to-clinical transition remains a major bottleneck for targeted radiotherapies due to their complexity and novelty. Traditional dosimetry translation methods rely primarily on decay rates and interspecies scaling of body and organ weights, often neglecting biological determinants of exposure. QSP modeling incorporates species-specific PK, tissue distribution, and clearance mechanisms, as well as interpatient variability in target expression—factors that critically shape…
